-
Nasdaq-Listed Field Trip Gets First Patent Approved For Improved Psychedelic Drug
Tuesday, April 5, 2022 - 3:32pm | 485Field Trip Health Ltd. (NASDAQ: FTRP), a biotech and care delivery company in the psychedelics space, has been granted its first patent by the U.S. Patent and Trademark Office. The patent covers claims around FT-104, the company’s flagship proprietary psychedelic molecule, for composition of...